Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Genadieva-Stavrik S.; Boumendil A.; Dreger P.; Peggs K.; Briones J.; Corradini P.; Bacigalupo A.; Socie G.; Bonifazi F.; Finel H.; Velardi A.; Potter M.; Bruno B.; Castagna L.; Malladi R.; Russell N.; Sureda A.

首页> 外文期刊>Annals of oncology: official journal of the European Society for Medical Oncology >Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

【24h】

Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

机译：近年异基因干细胞移植与强度降低的异体干细胞移植治疗复发性/难治性霍奇金淋巴瘤的关系：对欧洲血液和骨髓移植小组淋巴瘤工作组的回顾性分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: To evaluate long-term outcome of myeloablative allogeneic stem cell transplantation (allo-SCT) (MAC) versus reduced-intensity allo-SCT (RIC) in patients with relapsed/refractory Hodgkin's lymphoma (HL) in recent years.

机译：背景：评价近年来复发/难治性霍奇金淋巴瘤（HL）患者的清髓同种异体干细胞移植（allo-SCT）（MAC）与强度降低的allo-SCT（RIC）的长期疗效。

著录项

来源
《Annals of oncology: official journal of the European Society for Medical Oncology》 |2016年第12期|共7页
作者
Genadieva-Stavrik S.; Boumendil A.; Dreger P.; Peggs K.; Briones J.; Corradini P.; Bacigalupo A.; Socie G.; Bonifazi F.; Finel H.; Velardi A.; Potter M.; Bruno B.; Castagna L.; Malladi R.; Russell N.; Sureda A.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
relapsed/refractory Hodgkin's lymphoma; allogeneic stem cell transplantation; conditioning regimen;

机译：复发/难治性霍奇金淋巴瘤;异基因干细胞移植;适应方案;

相似文献

外文文献
中文文献
专利

1. Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation [J] . Genadieva-Stavrik S., Boumendil A., Dreger P., Annals of oncology: official journal of the European Society for Medical Oncology . 2016,第12期

机译：近年异基因干细胞移植与强度降低的异体干细胞移植治疗复发性/难治性霍奇金淋巴瘤的关系：对欧洲血液和骨髓移植小组淋巴瘤工作组的回顾性分析
2. Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. [J] . Sureda A, Robinson S, Canals C, Journal of Clinical Oncology . 2008,第3期

机译：在复发性或难治性霍奇金淋巴瘤中与常规同种异体干细胞移植相比，强度降低的条件：来自欧洲血液和骨髓移植小组淋巴瘤工作组的分析。
3. FLAMSA-Based Reduced-Intensity Conditioning versus Myeloablative Conditioning in Younger Patients with Relapsed/Refractory Acute Myeloid Leukemia with Active Disease at the Time of Allogeneic Stem Cell Transplantation: An Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation [J] . Rodriguez-Arboli Eduardo, Labopin Myriam, Tischer Johanna, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2020,第11期

机译：基于FLAMSA的减少强度调节与年幼患者的霉菌调节，在同种异体干细胞移植时具有活跃疾病的年轻患者中患者中患者：欧洲血和骨髓移植急性白血病工作组的分析
4. HEMOPOIETIC STEM CELL TRANSPLANTATION (HSCT) FOR PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) and ACQUIRED SEVERE APLASTIC ANEMtA (SAA):a report from the SAA Working Party of the European Blood and Marrow Transplant group (EBMT) [C] . Andrea Bacigalupo, Rosi Oneto, Barbara Bruno, International Symposium on PNH and Related Disorders . 2003

机译：血液发作干细胞移植（HSCT）用于阵发性夜间血红蛋白（PNH）和获得的严重Aplastic Anemta（SAA）：来自欧洲血液和骨髓移植组的SAA工作组（EBMT）的报告
5. Children with acute leukemia: A comparison of outcomes and cost-effectiveness from allogeneic blood stem cell and bone marrow transplantation. [D] . Lin, Yu-Feng. 2009

机译：儿童急性白血病：同种异体造血干细胞和骨髓移植的疗效和成本效益比较。
6. Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin’s lymphoma. Results of the HDR-ALLO study – a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation [O] . Anna Sureda, Carme Canals, Reyes Arranz, 2012

机译：复发或难治性霍奇金淋巴瘤患者降低强度条件后进行同种异体干细胞移植。 HDR-ALLO研究的结果–一项由GrupoEspañolde Linfomas / Trasplante deMédulaOsea（GEL / TAMO）和欧洲血液和骨髓移植小组淋巴瘤工作组进行的前瞻性临床试验
7. Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin’s lymphoma. Results of the HDR-ALLO study – a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation [O] . Sureda, Anna, Canals, Carme, Arranz, Reyes, 2011

机译：复发或难治性霍奇金淋巴瘤患者降低强度条件后进行同种异体干细胞移植。 HDR-ALLO研究的结果–一项由GrupoEspañolde Linfomas / Trasplante deMédulaOsea（GEL / TAMO）和欧洲血液和骨髓移植小组淋巴瘤工作组进行的前瞻性临床试验

Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

摘要

著录项

相似文献

相关主题

期刊订阅